|
|
Volumn 18, Issue 2, 2001, Pages 363-367
|
|
Enhancement of antitumor effect by intratumoral administration of bax gene in combination with anticancer drugs in gastric cancer.
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BAX PROTEIN, HUMAN;
BAX PROTEIN, MOUSE;
CATION EXCHANGE RESIN;
CISPLATIN;
DOCETAXEL;
DRUG DERIVATIVE;
DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS;
FLUOROURACIL;
LIPID;
LIPOFECTAMINE;
ONCOPROTEIN;
PACLITAXEL;
PROTEIN BAX;
PROTEIN BCL 2;
TAXOID;
ANIMAL;
APOPTOSIS;
ARTICLE;
CELL CULTURE;
DRUG EFFECT;
DRUG SCREENING;
GENE THERAPY;
HUMAN;
METABOLISM;
METHODOLOGY;
MOUSE;
MULTIMODALITY CANCER THERAPY;
NUDE MOUSE;
PHYSIOLOGY;
STOMACH TUMOR;
ANIMALS;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
APOPTOSIS;
BCL-2-ASSOCIATED X PROTEIN;
CATION EXCHANGE RESINS;
CISPLATIN;
COMBINED MODALITY THERAPY;
FLUOROURACIL;
GENE THERAPY;
HUMANS;
INDICATORS AND REAGENTS;
LIPIDS;
MICE;
MICE, NUDE;
PACLITAXEL;
PROTO-ONCOGENE PROTEINS;
PROTO-ONCOGENE PROTEINS C-BCL-2;
STOMACH NEOPLASMS;
TAXOIDS;
TUMOR CELLS, CULTURED;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
MLCS;
MLOWN;
|
|
EID: 0035260492
PISSN: 10196439
EISSN: None
Source Type: Journal
DOI: 10.3892/ijo.18.2.363 Document Type: Article |
|
Times cited : (24)
|
|
References (0)
|
